{
    "clinical_study": {
        "@rank": "142967", 
        "arm_group": [
            {
                "arm_group_label": "Succinylcholine", 
                "arm_group_type": "Active Comparator", 
                "description": "Patient receive succinylcholine as a muscle relaxant (0,5mg/kg) after induction of general anaesthesia for rigid bronchoscopy."
            }, 
            {
                "arm_group_label": "Mivacurium", 
                "arm_group_type": "Active Comparator", 
                "description": "Patients receive mivacurium (0,08mg/kg) as a muscle relaxant after induction of general anaesthesia for rigid bronchoscopy. At the end of the procedure and a twitch of 25% mivacurium was reversed with neostigmine (50 microg/kg) and atropin (10 microg/kg)"
            }
        ], 
        "brief_summary": {
            "textblock": "Succinylcholine is commonly used for neuromuscular relaxation for short procedures such as\n      rigid bronchoscopy. A alternative is the application of low dose mivacurium, reversed with\n      neostigmine. The investigators compare the intubating conditions, incidence of postoperative\n      myalgia (POM), patient satisfaction and the postoperative performance with respiration\n      exercise device for these two muscle relaxants."
        }, 
        "brief_title": "Low Dose Mivacurium vs. Low Dose Succinylcholine for Rigid Bronchoscopy", 
        "condition": [
            "Intubating Conditions", 
            "Performance With Respiratory Exercise Device", 
            "Postoperative Myalgia"
        ], 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  age > 18 yr\n\n          -  scheduled for elective rigid bronchoscopy\n\n        Exclusion Criteria:\n\n          -  known neuromuscular disease\n\n          -  significant hepatic or renal dysfunction\n\n          -  family history of malignant hyperthermia\n\n          -  known allergy to one of the drugs used in this protocol\n\n          -  pregnancy or breastfeeding"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 17, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01966484", 
            "org_study_id": "HSK003"
        }, 
        "intervention": [
            {
                "arm_group_label": "Succinylcholine", 
                "description": "Anaesthesia was induced and maintained with propofol(1-2mg/kg and 5mg/kg/h) and remifentanil (1\u00b5g/kg and 0,2\u00b5/kg/min). The study arm is immobilized and a dual electrode for peripheral nerve stimulation is placed over the ulnar nerve near the wrist. Neuromuscular monitoring is performed with accelerometry. the patients receive the muscle relaxant according to the study group.", 
                "intervention_name": "Succinylcholine", 
                "intervention_type": "Drug", 
                "other_name": [
                    "Succinylcholine", 
                    "Mivacurium", 
                    "Rigid Bronchoscopy"
                ]
            }, 
            {
                "arm_group_label": "Mivacurium", 
                "description": "Anaesthesia was induced and maintained with propofol(1-2mg/kg and 5mg/kg/h) and remifentanil (1\u00b5g/kg and 0,2\u00b5/kg/min). The study arm is immobilized and a dual electrode for peripheral nerve stimulation is placed over the ulnar nerve near the wrist. Neuromuscular monitoring is performed with accelerometry. the patients receive the muscle relaxant according to the study group.", 
                "intervention_name": "Mivacurium", 
                "intervention_type": "Drug", 
                "other_name": [
                    "Succinylcholine", 
                    "Mivacurium", 
                    "Rigid Bronchoscopy"
                ]
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Succinylcholine", 
                "Mivacurium"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Succinylcholine", 
            "Mivacurium", 
            "Rigid Bronchoscopy", 
            "Intubating conditions", 
            "Short Procedure"
        ], 
        "lastchanged_date": "December 10, 2013", 
        "location": {
            "contact": {
                "email": "verena.ghezel-ahmadi@hsk-wiesbaden.de", 
                "last_name": "Verena Ghezel-Ahmadi, Dr", 
                "phone": "0049611432176"
            }, 
            "facility": {
                "address": {
                    "city": "Wiesbaden", 
                    "country": "Germany", 
                    "zip": "65199"
                }, 
                "name": "Dr. Horst Schmidt Klinik GmbH"
            }, 
            "investigator": {
                "last_name": "Verena Ghezel-Ahmadi, Dr", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_arms": "2", 
        "other_outcome": {
            "description": "Measurement on a numeric ten point scale (10=totally satisfied)", 
            "measure": "Patient satisfaction", 
            "safety_issue": "No", 
            "time_frame": "72 hours after intervention"
        }, 
        "overall_contact": {
            "email": "grietje.beck@hsk-wiesbaden.de", 
            "last_name": "Grietje Beck, Prof", 
            "phone": "0049611432176"
        }, 
        "overall_contact_backup": {
            "email": "verena.ghezel-ahmadi@hsk-wiesbaden.de", 
            "last_name": "Verena Ghezel-Ahmadi, Dr", 
            "phone": "0049611432176"
        }, 
        "overall_official": {
            "affiliation": "Dr. Horst Schmidt Klinik GmbH 65199 Wiesbaden, Germany", 
            "last_name": "Grietje Beck, Prof", 
            "role": "Study Chair"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Germany: Federal Institute for Drugs and Medical Devices", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "For measuring the intubation conditions the scoring system proposed for Good clinical Research Practice using the following variables is used: conditions of inserting the rigid bronchoscope, vocal cord position and coughing", 
            "measure": "Intubating condition", 
            "safety_issue": "No", 
            "time_frame": "After induction of general anaesthesia (after 3-5 minutes)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01966484"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "The severity of POM was measured using a four point scale:\n0=no myalgia\nminor pain limited to one area of the body\nmuscle pain or stiffness noticed spontaneously by the patient, which may have required analgesic therapy\ngeneralized, severe or incapacitating discomfort", 
                "measure": "Postoperative Myalgia", 
                "safety_issue": "No", 
                "time_frame": "72 hours after intervention"
            }, 
            {
                "description": "The performance with a respiration exercise device, which measures the expirational volume, before and after intervention.", 
                "measure": "postintervention performance with a expiration exercise device", 
                "safety_issue": "No", 
                "time_frame": "72 hours after intervention"
            }
        ], 
        "source": "Dr. Horst Schmidt Klinik GmbH", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Dr. Horst Schmidt Klinik GmbH", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "October 2013", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}